Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Slit3 ELISA Kit (AC2925)
Cat.#: ASET-1514
Specifications
Description Human Slit3 ELISA Kit allows for the in vitro quantitative determination of human Slit3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1359 Mouse Creatine Kinase B Type ELISA Kit (AC2770) Quantitative inquiry ASET-2414 Human TGFBI ELISA Kit (AC3825) Quantitative inquiry ASET-1185 Human NMDAR2A ELISA Kit (AC2596) Quantitative inquiry ASET-2132 Human Mitofusin 2 ELISA Kit (AC3543) Quantitative inquiry ASET-1870 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3281) Quantitative inquiry ASET-2258 Human CBLN2 ELISA Kit (AC3669) Quantitative inquiry ASET-1884 Human LMX1b ELISA Kit (AC3295) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry ASET-1815 Human COCH ELISA Kit (AC3226) Quantitative inquiry ASET-1125 Human APH1A ELISA Kit (AC2536) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket